The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes

Article Abstract:

High blood levels of B-type natriuretic peptide in patients with symptoms of a heart attack or unstable chest pain is a sign of a poor prognosis, according to a study of 2,525 patients. This peptide is a hormone produced by the heart under certain conditions.

Prognosis, Unstable angina, Heart attack, Natriuretic peptides

---

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

Article Abstract:

The risk of Cardiovascular events may be reduced by Lipid-lowering therapy with statins. An intensive lipid-lowering statin regimen provides greater protection against death or major cardiovascular events for patients who have had an acute coronary syndrome.

United States, Evaluation, Cardiovascular diseases, Drug therapy, Antilipemic agents, Statins

---

Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome

Article Abstract:

The antibiotic treatment of Chlamydia pneumoniae found within atherosclerotic plaques, and elevated titers of antibody to this organism linked to a higher risk of coronary events is studied. It is concluded that despite long-term treatment with a bactericidal antibiotic effective against Chlamydia pneumoniae, no reduction in the rate of cardiovascular events was observed.

New England States, Care and treatment, Antibiotics, Coronary heart disease, New England, Chlamydia

Similar abstracts:

• Abstracts: The risk of stomach cancer in patients with gastric or duodenal ulcer disease. Obesity, hypertension, and the risk of kidney cancer in men
• Abstracts: The frequency and clinical significance of intra-amniotic inflammation in patients with a positive cervical fetal fibronectin
• Abstracts: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
• Abstracts: Development and progression of renal disease in Pima indians with non-insulin-dependent diabetes mellitus. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
• Abstracts: Ethical issues concerning research in complementary and alternative medicine. The ethics of placebo-controlled trials -- a middle ground

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.